Sees FY23 adjusted EBITDA 18%-19%. Sees FY25 revenue $600M-$700M. Sees FY25 adjusted EBITDA margin 25%-30%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SKIN:
- The Beauty Health (NASDAQ:SKIN) Glows On Healthy Q2 Numbers
- Short Report: Carvana short squeeze sends bearish position to 2023 lows
- Beauty Health: SkinStylus receives new FDA clearance for facial acne scarring
- Unusual call flow in option market yesterday
- Call volume 40x normal in Beauty Health Co as shares lift